The conformational changes in NM that lead to amyloid formation in vitro serve as a model for the self-perpetuating conformational changes in Sup35p that allow this protein to serve as an epigenetic element of inheritance in vivo.
Directed differentiation in vitro served as an initial step that induced expression of relevant endocrine genes.
Under inflammatory conditions, monocytes can turn into inflammatory moDC, which can be generated in vitro serving as an appropriate model for studying DC [ 31].
Notably, in mathematics, as in biology, characterization of a simplified system (such as an in-vitro experiment) serves as a building block for more complex systems.
In addition, the interference of phospholipase D in the attenuation of hemolysis caused by β-hemolysin from Staphylococcus aureus has been documented in vitro, which serves as an auxiliary test in the identification of C. pseudotuberculosis.
To address experimentally whether DRIL1 is modified by SUMO, we used an in vitro-reconstituted sumoylation assay, in which a 35S-labeled DRIL1, generated by in vitro translation, serves as a target for SUMO modification in the presence of recombinant E1 (the Aos1/Uba2 heterodimer), recombinant Ubc9, SUMO1, and ATP.
Thus the in vitro condition serves to identify TGF-β target genes, but it does not indicate the direction of their regulation in the in vivo context and hence cannot predict the critical issue of biological outcome (tumor suppression vs. tumor progression).
Results of phantom experiments show agreement (12.5% normalized rms deviation) between control volume derived and directly measured pressure differential in vitro which serves as a proof-of-concept for determining in vivo pressure differentials non-invasively using control volume analysis and flow-sensitive magnetic resonance imaging.
Therefore, in vitro systems serve as ideal tools to study these cellular interactions.
Here, we review recent technological advances and further discuss how these technologies are complementary, and could therefore be combined for the biofabrication of organotypic tissues either in vitro, thus serving as realistic tissue models, or within a clinic setting.
